PQR-309(Bimiralisib)

产品编号: DC8335 Featured
PQR-309(Bimiralisib)
结构式
1225037-39-7
此产品仅供科研所需,我们不出售给病人
​我们将匹配市场上最好的价格给您
Email:order@dcbio.cn
免费咨询电话:4008862077
我们的合作伙伴:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
中国地区超过5000个高品质化合物库存
应用领域
Bimiralisib (PQR309) 是一种有效的,可渗透脑的,PI3K/mTOR 抑制剂,抑制 PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ 和 mTOR,IC50 分别为 33 nM,451 nM,661 nM,708 nM 和 89 nM。Bimiralisib 是 mTORC1 和 mTORC2 抑制剂。
Cas No.: 1225037-39-7
名称:
别名: PQR309,PQR 309,PQR-309
SMILES: C(N)1=NC=C(C2=NC(N3CCOCC3)=NC(N3CCOCC3)=N2)C(C(F)(F)F)=C1
分子式: C17H20F3N7O2
分子量: 411.38
纯度:
保存条件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description:
In Vivo:
In Vitro:
References: PI3K-IN-2 is a PI3K inhibitor, inhibits pPKB and pS6 with "++++/+++(+)" in A2058 melanoma cell. For the detailed information of PI3K-IN-2, the solubility of PI3K-IN-2 in water, the solubility of PI3K-IN-2 in DMSO, the solubility of PI3K-IN-2 in PBS buffer, the animal experiment (test) of PI3K-IN-2, the cell expriment (test) of PI3K-IN-2, the in vivo, in vitro and clinical trial test of PI3K-IN-2, the EC50, IC50,and affinity,of PI3K-IN-2, For the detailed information of PI3K-IN-2, the solubility of PI3K-IN-2 in water, the solubility of PI3K-IN-2 in DMSO, the solubility of PI3K-IN-2 in PBS buffer, the animal experiment (test) of PI3K-IN-2, the cell expriment (test) of PI3K-IN-2, the in vivo, in vitro and clinical trial test of PI3K-IN-2, the EC50, IC50,and affinity,of PI3K-IN-2, Please contact DC Chemicals.
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
产品编号 产品名称 应用领域
DC9708 GDC-0084(RG7666) GDC-0084 是一种能透过血脑屏障的 PI3K 和 mTOR 抑制剂,抑制 PI3Kα,PI3Kβ,PI3Kδ,PI3Kγ 和 mTOR,Ki 值分别为 2 nM,46 nM,3 nM,10 nM 和 70 nM。
DC8335 PQR-309(Bimiralisib) Bimiralisib (PQR309) 是一种有效的,可渗透脑的,PI3K/mTOR 抑制剂,抑制 PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ 和 mTOR,IC50 分别为 33 nM,451 nM,661 nM,708 nM 和 89 nM。Bimiralisib 是 mTORC1 和 mTORC2 抑制剂。